eCAP - eHealth CAPsule for digestive disease diagnostic and therapy

ECAP的目标是提供一种新型医疗设备，将智能胶囊与电子健康平台相结合，以实现更好的诊断、患者赋权的疾病管理，从而改善胃肠道(GI)疾病患者的预后。我们的项目将创建一种具有多传感能力的模块化可植入胶囊，利用灵活的内窥镜这一微创手术方法，在一段可控的时间内实现胃肠道生理监测。ECAP将使用全球普遍存在的智能手机通信标准，结合云计算技术和应用程序接口来整合、处理和解释太空舱收集的纵向生理数据。数字平台旨在通过纳入患者报告的结果测量来提高标准测试数据的准确性和临床实用性。临床医生能够为患者个性化测试，并通过人工智能辅助的解释从这种多流数据输入中接收准确和有意义的结果。ECAP解决方案的普遍性将使先进的胃肠道疾病诊断技术能够传播给世界各地的患者和医生，包括资源匮乏的环境。在项目期间，我们将展示ECAP？S的临床价值和成本节约，将胃食道反流病作为临床目标，这是一个世界性的、常见的和极其昂贵的问题。将在法国、乌克兰和肯尼亚进行临床评估和卫生经济学分析，并将制定一个专门的教育计划，培训从业者使用这项新技术。ECAP建立在我们的财团在用于胃肠道疾病诊断的植入式胶囊领域数年的研发基础上。它的雄心是促进GI诊断从目前不可扩展的模拟版本转变为以患者为中心的电子健康工具，并使欧洲成为快速增长的远程患者监护联网医疗设备领域的领先者。

eCAP aims to deliver a novel medical device which combines a smart capsule with an e-health platform for better diagnostics,patient empowered disease management and hence, improved outcomes for patients with gastrointestinal (GI) diseases. Our projectwill create a modular and implantable capsule with multi-sensing capacity that enables GI physiology monitoring for a controlledtime period, leveraging the minimally invasive surgical approach of flexible endoscopy. eCAP will use a worldwide ubiquitoussmartphone communication standard, together with cloud computing technology and application interfaces to integrate, process andinterpret longitudinal physiological data collected by the capsule. The digital platform is designed to improve the accuracy and clinicalusefulness of standard test data by incorporating patient reported outcome measures. The clinician is able to personalize the testfor the patient and receive accurate and meaningful results from this multi-stream data input with interpretation aided by ArtificialIntelligence. The universality of the eCAP solution will allow dissemination of advanced GI disease diagnostics to patients and doctorsworldwide, including low resource environments. During the project, we will demonstrate eCAP?s clinical value and cost savings usinggastroesophageal reflux disease (GERD), a worldwide, common, and extremely costly problem, as a clinical target. Clinical evaluationwith health-economics analysis will be conducted in France, Ukraine and Kenya, and a specific education program will be developedto train practitioners to use the novel technology. eCAP builds on several years of R&D by our consortium in the field of implantablecapsules for GI disease diagnostics. Its ambition is to facilitate a shift in GI diagnostics from its current unscalable analogue versionto a patient centered e-health tool and to make Europe the leader in the rapidly growing field of connected medical devices for remotepatient monitoring.